The company said its board declared a regular quarterly dividend of $1.35 per common share on June 13, 2025. The dividend is payable on July 15, 2025.

8-KRegulation FD DisclosureFiled Jun 13, 2025Period of report Jun 13, 2025Summary published (UTC) Oct 14, 2026

Key points

AI summary

The company said its board declared a regular quarterly dividend of $1.35 per common share on June 13, 2025. The dividend is payable on July 15, 2025.
Philip Morris International said it will pay the dividend to shareholders of record as of June 27, 2025. The ex-dividend date is June 27, 2025.
PM said smoke-free products were available for sale in 95 markets as of December 31, 2024, and that it estimates they were used by about 38.6 million adults. The smoke-free business accounted for 42% of total net revenues for Q1 2025.
The company said it has invested over $14 billion since 2008 to develop, scientifically substantiate and commercialize smoke-free products. The company said the U.S. FDA authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches, and some IQOS devices and consumables.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Philip Morris Declares Quarterly Dividend of $1.35 per Share

The company said its board declared a regular quarterly dividend of $1.35 per common share on June 13, 2025. The dividend is payable on July 15, 2025.

Source · Based on the filing body and exhibits

Dividend Record and Ex-Dividend Dates, June 27

Philip Morris International said it will pay the dividend to shareholders of record as of June 27, 2025. The ex-dividend date is June 27, 2025.

Source · Based on the filing body and exhibits

Smoke-Free Product Markets and Revenue Share

PM said smoke-free products were available for sale in 95 markets as of December 31, 2024, and that it estimates they were used by about 38.6 million adults. The smoke-free business accounted for 42% of total net revenues for Q1 2025.

Source · Based on the filing body and exhibits

Smoke-Free Investment and FDA Authorizations Since 2008

The company said it has invested over $14 billion since 2008 to develop, scientifically substantiate and commercialize smoke-free products. The company said the U.S. FDA authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches, and some IQOS devices and consumables.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.